Eli Lilly slips, Novo Nordisk holds firm as generic weight-loss drugs flood India
- Posted on April 10, 2026
- By CNBC
- 10 Views
Eli Lilly slips, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
